• University of California, San Francisco Opens Bakar Precision Cancer Medicine Building


    The University of California, San Francisco opened the $275 million Precision Cancer Medicine Building (PCMB) in June of 2019.

  • The Future of Xenotransplantation—Thinking Outside the Walls


    With demand for human donor organs historically and increasingly outpacing the available, viable supply, researchers and physicians have looked for decades at xenotransplantation—cross-species transplantation—as a possible vehicle to overcome the problem. The traditional approach to xenotransplantation, however, is an “impediment to moving transplantation forward,” asserts Karl Kraebber, director of xenotransplantation operations at the University of Alabama at Birmingham School of Medicine. His team believes the solution isn’t in expensive and time-consuming renovation of existing buildings. “Our more novel approach is for flexible, modular spaces, to be used for small pilot trials and then scaled up once we have partnership with our governing agencies,” he says. “We’ll take ‘fast and good’ over ‘slow and perfect’ every time. It doesn’t mean we’re cutting corners.”

  • University of Toronto Plans Schwartz Reisman Innovation Centre


    The University of Toronto is planning to create Canada's largest university-based innovation node with the construction of the 750,000-sf Schwartz Reisman Innovation Centre.

  • Eisai Creates Center for Genetics Guided Dementia Discovery


    Eisai is building the $100 million Center for Genetics Guided Dementia Discovery (G2D2) in Cambridge, Mass.

  • Cellectis Constructs Innovative Manufacturing Plant for Allogeneic Cellular Therapies


    Cellectis entered into a lease agreement in March of 2019 to build the Innovative Manufacturing Plant for Allogeneic Cellular Therapies (IMPACT) in Raleigh, N.C.

  • Amicus Therapeutics Creates Global Research and Gene Therapy Center of Excellence


    Amicus Therapeutics is creating the Global Research and Gene Therapy Center of Excellence in Philadelphia. The 75,000-sf facility will provide collaborative laboratories and offices for the discovery and development of treatments for rare metabolic diseases.

  • Akouos Leases Biotech Headquarters in Boston


    Akouos, a genetic medicine company, has leased 37,500 sf in Boston for its research headquarters.

  • University of IdahoIntegrated Research and Innovation Center


    The Integrated Research and Innovation Center (IRIC) at the University of Idaho houses more than 20 grant-funded teams of faculty and graduate and undergraduate researchers, representing every college at the university, who collaborate on cross-department research in the hard sciences, social sciences, and humanities. No one “owns” any space in the building; instead, teams rotate in and out of the facility based on project lifespan, from a few months to several years, requiring a flexible and adaptable design.

  • Brammer Bio Constructs Gene Therapy Manufacturing Facilities


    Brammer Bio is developing two gene therapy manufacturing facilities in Massachusetts. The company will build out 35,000 sf in an existing 50,000-sf structure in Lexington to create a cGMP manufacturing and quality control operations center.

  • Fujifilm Cellular Dynamics Creates Biomanufacturing Center


    Fujifilm Cellular Dynamics is creating a stem cell manufacturing center in Madison, Wis. Located in the University Research Park, the $21 million project involves the renovation of 31,500 sf in a facility near the company's existing lab and office building.